Literature DB >> 1924395

Critical role of a hydrogen bond in the interaction of phospholipase A2 with transition-state and substrate analogues.

L Yu1, E A Dennis.   

Abstract

The inhibition of phospholipase A2 by an amide substrate analogue, 1-hexadecylthio-2-hexadecanoyl-amino-1,2-dideoxy-sn-glycero-3-phos phocholine, and a phosphonate transition-state analogue, 1-hexadecylthio-1-deoxy-2-hexadecylphosphono-sn-glycero-3-ph osphocholine, is dramatically influenced by pH. However, these two inhibitors show opposite pH dependencies. The amide analogue acts more potently under basic conditions, whereas the phosphonate acts more potently under acidic conditions. In both cases, ligand binding is perturbed by protonation of an enzyme functional group with an apparent pKa of 6.1, which corresponds to that of a histidine residue. Thus, His-48, which has previously been implicated in catalysis, appears to be critically involved in the hydrogen bond interactions between the enzyme and these two inhibitors. The amide analogue binds most effectively to the enzyme when His-48 is deprotonated. Upon protonation of the histidine residue, the amide cannot form a critical hydrogen bond and loses its ability to interact effectively with the enzyme. In contrast, the phosphonate analogue binds much tighter to the protonated form of the enzyme than to the deprotonated form. The phosphonate analogue needs a bridging hydrogen between the oxygen on its phosphorus atom and the N delta 1 of His-48 to form a strong hydrogen bond. At optimal pH values for inhibitor binding, both the amide and the phosphonate analogues are potent competitive inhibitors of cobra (Naja naja naja) venom phospholipase A2. The IC50 for the amide was 4.4 x 10(-4) mol fraction and for the phosphonate was 1.6 x 10(-5) mol fraction. Under the experimental conditions used, this corresponds to a bulk concentration of 2 microM and 70 nM, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924395      PMCID: PMC52707          DOI: 10.1073/pnas.88.20.9325

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Transition state analog inhibitors and enzyme catalysis.

Authors:  R Wolfenden
Journal:  Annu Rev Biophys Bioeng       Date:  1976

2.  Spectral perturbations of the histidine and tryptophan in cobra venom phospholipase A2 upon metal ion and mixed micelle binding.

Authors:  M F Roberts; R A Deems; E A Dennis
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

3.  Thio-based phospholipase assay.

Authors:  L Yu; E A Dennis
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Kinetic analysis of phospholipase A2 activity toward mixed micelles and its implications for the study of lipolytic enzymes.

Authors:  R A Deems; B R Eaton; E A Dennis
Journal:  J Biol Chem       Date:  1975-12-10       Impact factor: 5.157

5.  Histidine at the active site of phospholipase A2.

Authors:  J J Volwerk; W A Pieterson; G H de Haas
Journal:  Biochemistry       Date:  1974-03-26       Impact factor: 3.162

6.  Enzymatic catalysis and transition-state theory.

Authors:  G E Lienhard
Journal:  Science       Date:  1973-04-15       Impact factor: 47.728

7.  Chemical modification of the histidine residue in phospholipase A2 (Naja naja naja). A case of half-site reactivity.

Authors:  M F Roberts; R A Deems; T C Mincey; E A Dennis
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

8.  Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism.

Authors:  H M Verheij; J J Volwerk; E H Jansen; W C Puyk; B W Dijkstra; J Drenth; G H de Haas
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

9.  Phospholipid activation of cobra venom phospholipase A2. 1. Lipid--lipid or lipid--enzyme interaction.

Authors:  M F Roberts; M Adamich; R J Robson; E A Dennis
Journal:  Biochemistry       Date:  1979-07-24       Impact factor: 3.162

10.  Phospholipid activation of cobra venom phospholipase A2. 2. Characterization of the phospholipid--enzyme interaction.

Authors:  M Adamich; M F Roberts; E A Dennis
Journal:  Biochemistry       Date:  1979-07-24       Impact factor: 3.162

View more
  12 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Synthesis, characterization and bioactivity studies of novel 1,3,4-oxadiazole small molecule that targets basic phospholipase A2 from Vipera russelli.

Authors:  Vivek Hamse Kameshwar; Kumar J R; Babu S Priya; S Nanjunda Swamy
Journal:  Mol Cell Biochem       Date:  2016-12-07       Impact factor: 3.396

3.  Solution structure of porcine pancreatic phospholipase A2 complexed with micelles and a competitive inhibitor.

Authors:  B van den Berg; M Tessari; R Boelens; R Dijkman; R Kaptein; G H de Haas; H M Verheij
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

Review 4.  Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease.

Authors:  Edward A Dennis
Journal:  J Biol Chem       Date:  2016-08-23       Impact factor: 5.157

5.  Light controls phospholipase A2alpha and beta gene expression in Citrus sinensis.

Authors:  Hui-Ling Liao; Jacqueline K Burns
Journal:  J Exp Bot       Date:  2010-04-13       Impact factor: 6.992

Review 6.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

Review 7.  Phospholipase A2 structure/function, mechanism, and signaling.

Authors:  John E Burke; Edward A Dennis
Journal:  J Lipid Res       Date:  2008-11-14       Impact factor: 5.922

8.  Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.

Authors:  R W Schevitz; N J Bach; D G Carlson; N Y Chirgadze; D K Clawson; R D Dillard; S E Draheim; L W Hartley; N D Jones; E D Mihelich
Journal:  Nat Struct Biol       Date:  1995-06

9.  The binding of amide substrate analogues to phospholipase A2. Studies by 13C-nuclear-magnetic-resonance and infrared spectroscopy.

Authors:  P K Slaich; W U Primrose; D H Robinson; C W Wharton; A J White; K Drabble; G C Roberts
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

10.  Development of a Novel Tetravalent Synthetic Peptide That Binds to Phosphatidic Acid.

Authors:  Rina Ogawa; Kohjiro Nagao; Kentaro Taniuchi; Masaki Tsuchiya; Utako Kato; Yuji Hara; Takehiko Inaba; Toshihide Kobayashi; Yoshihiro Sasaki; Kazunari Akiyoshi; Miho Watanabe-Takahashi; Kiyotaka Nishikawa; Masato Umeda
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.